Search Results

PurMinds NeuroPharma (“PurMinds” or the “Company”), a neuro-medicine development company focused on advancing novel therapeutics for neurological and neurodegenerative disorders, today announced that it has signed the first Controlled Substances Supply Agreement with Bluestem API Inc (“Bluestem”) to produce and supply botanical psilocybin from its Ontario based neurolab and production facility that holds a Dealer’s License for Controlled Drugs and Substances (“DL”).

Acuant , a leading global provider of identity verification, today announced that NeuroLab BI is using Acuant technology to verify the personal data of COVID-19 patients, enabling clinical laboratories to enter complete and accurate patient information into their electronic medical records systems quickly, efficiently an

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on advancing a robust pipeline of small molecules, psychedelic compounds, and other modalities for the treatment of neurological and neurodegenerative disorders

PurMinds NeuroPharma to initiate preclinical development of lead candidate PUR501 in 2024 in preparation for IND submission

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on advancing a robust pipeline of small molecules, psychedelic compounds, and other modalities for the treatment of neurological and neurodegenerative disorders

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders

PurMinds NeuroPharma Inc. (“PurMinds™" or the “Company”), a clinical-stage neuroscience company dedicated to the development of innovative therapies for neurological and neurodegenerative disorders

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules,

PurMinds NeuroPharma (“PurMinds” or the “Company”), a neuroscience company with a robust clinical pipeline combining small molecules, psychedelic compounds and other modalities

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities